A four‐long noncoding RNA signature predicts survival of hepatocellular carcinoma patients. Issue 9 (30th May 2020)

• Record Type: Journal Article
• Authors: Jiang, Haitao; Zhao, Lianhe; Chen, Yunjie; Sun, Liang
• Is Part Of: Journal of clinical laboratory analysis. Volume 34:Issue 9(2020)
• Page Start: n/a
• Page End: n/a
• Publication Date: 2020-05-30
• Subjects: biomarker -- hepatocellular carcinoma -- lncRNA -- prognostic -- signature; Diagnosis, Laboratory -- Periodicals; Medical laboratory technology -- Periodicals; 616
• DOI: 10.1002/jcla.23377
• Languages: English
• ISSNs: 0887-8013

Abstract

Abstract: Background: Hepatocellular carcinoma (HCC) is a common neoplasm located in the liver. Accumulating evidence has highlighted that long noncoding RNAs (lncRNAs) are correlated with the survival of HCC patients. This study focuses on finding a lncRNA signature to predict the prognostic risk of HCC patients. Methods: Statistical and machine learning analyses were conducted to analyze the lncRNA expression data and corresponding clinical data of 180 HCC patients collected from the public online Tanric and The Cancer Genome Atlas (TCGA) databases. Results: From the training dataset, we obtained the four‐lncRNA model comprising RP11‐495K9.6, RP11‐96O20.2, RP11‐359K18.3, and LINC00556 which can divide HCC patients into two different groups with significantly different prognosis (n = 90, median 1.81, 95% confidence interval [CI]: 1.50‐4.91 vs 8.56 years, 95% CI: 6.96‐9.97, log‐rank test P < .001). The test dataset confirmed the prognostic ability of the signature (n = 90, median 1.95, 95% CI: 1.14‐4.08 vs 5.80 years, 95% CI: 3.11‐6.82, log‐rank test P = .007). Receiver operating characteristic curve displayed the better prediction efficiency of the four‐lncRNA signature than the tumor/node/metastasis stage. Cox analysis showed the four‐lncRNA signature was an independent predictor of HCC prognosis. Conclusion: The four‐lncRNA signature can be used as an independent biomarker for HCC patients to predict the prognostic risk.